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Leucas aspera (Willd.) Link has been used for curing various ailments including skin disease in traditional medicine for 
decades. The aim of the study was to evaluate the in vitro antioxidant potential and anti-elastase activity of L. aspera (Willd.) Link. 
The hexane, ethyl acetate, acetone and ethanol extracts were prepared using the Soxhlet extraction method. The phytochemical 
analysis, in vitro free radical scavenging, and anti-elastase activities, were conducted. The total phenol and flavonoids compounds 
were found to be significantly high for the hexane extract and the ethyl acetate extract respectively. In vitro antioxidant assays like 
percentage reducing power, DPPH radical scavenging activity, the total antioxidant capacity by FRAP assay, revealed that the 
acetone extract of the plant L. aspera possesses significantly the highest activity. The anti elastase assay revealed that all the 
extracts possess elastase inhibitory activity and the hexane extract possessed significantly highest activity with IC50 of 247.42 
µg/mL, at a significant level (α) <0.05. The present result supports the traditional use of L. aspera. 
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Introduction 
Elastase is an enzyme capable of degrading 
extracellular matrix proteins which provides elasticity to 
connective tissues and has important role in many 
natural physiological processes. They take part in 
complete tissue recovery after healing of the wound by 
degrading the damaged tissue at the wound area. Under 
normal conditions, the levels of human neutrophil 
elastase (HNE) are controlled by endogenous factors. 
However, in chronic non-healing wounds, elevated 
levels of elastase may degrade growth factors and 
connective tissue proteins present in the surrounding 
area. An excessive and uncontrolled elastase activity is 
also associated with other major inflammatory diseases 
including rheumatoid arthritis, chronic obstructive 
pulmonary diseases, cystic fibrosis, ischemic 
reperfusion, injury, atherosclerosis, psoriasis, and 
malignant tumors1. Elastase inhibitors can be used 
therapeutically as a measure to restore the normal levels 
of elastase in the above diseases2. It may also be used in 
the healing of chronic wounds, anti-ageing and ant 
wrinkle treatments3. Due to these various applications, 
there has been considerable interest in the design of such 
elastase inhibitors1. 
The production of free radicals may lead to the 
destruction of the extracellular matrix, which became 
an initiation factor for ageing and various diseases. 
Antioxidant agents can preserve tissues viable, delay 
ageing and also facilitate healing of wounds4. 
Reactive oxygen species are deleterious to skin ageing 
due to their harmful effects on cells and tissues. 
Topical application of compounds with free radical 
scavenging properties, significantly protect tissues 
from oxidative damage5. Thus antioxidant compounds 
with anti elastase property could be used as a 
cosmetic ingredient to relieve skin ageing3. The 
interest in discovering novel natural cosmetic agents 
from medicinal plants is increasing among modern 
researchers as they are safe and easily available 
without any side effects. 
Medicinal plants are immensely rich sources of new 
pharmaceuticals, cosmetics and other economically 
important chemicals. Presently numerous pure 
compounds are isolated from plants for many 
therapeutic purposes. The plant L. aspera (Willd.) Link 
is a tropical plant mainly used for many diseases in 
traditional systems of medicine. L. aspera belongs to the 
family Labiatae, commonly known as “Thumbai”, 
which is distributed throughout India from the 








Dronapushpi and Gumma Bhaji. It is an annual herb 
found as a weed in cultivated fields, wastelands and 
roadsides. The plant has been used traditionally to cure 
boils, ulcers, bleeding piles, colds, colic, ear-aches, 
headaches and stomach aches and also for infectious 
diseases like fever, chronic cough, etc. The juice of the 
leaves is used to treat psoriasis, chronic skin eruptions 
and chronic rheumatism7. The plant is known to possess 
several medicinal properties8,9 such as anticaterogenic10, 
hepatoprotective11, antidiabetic12, antimicrobial13, 
larvicidal14, insecticidal15, wound healing16, anti-
inflammatory17, antidiabetic activity18 etc. Since  
L. aspera has long been used as a traditional remedy for 
wound healing and skin diseases, the aim of the present 
study was to evaluate the antioxidant and anti elastase 
activity of different extracts of L. aspera. 
Materials and Methods 
 
Plant collection 
The shoot of L. aspera was collected from Aromatic 
and Medicinal Plant Research Station, Kerala 
Agricutural University, Odackali, Perumbavoor, 
Eranakulam, Kerala and was identified by Dr Jomy 
Augustine, Head, Department of Botany, St.Thomas 
College, Pala, Kottayam, Kerala. Voucher specimen 
(Acc. No. 003401) was deposited in the Herbarium of 
Department of Botany, St.Thomas College, Pala, 
Kottayam, Kerala, for future reference. Fresh plant 
materials were first washed under running tap water, 
then washed with distilled water, and finally were dried 
in shade at room temperature. Dried leaves were ground 
into a fine powder and stored in an airtight bottle. 
 
Preparation of plant extracts 
The different plant extracts were prepared by soxhlet 
extraction method using solvents of increasing order of 
polarity for 72 hours successively until the extract 
became colourless or till the extraction was completed. 
The solvents used were hexane, acetone, ethyl acetate, 
and ethanol. The extracts were concentrated to dryness 
by vaccum rotary evaporator and the yield of the extracts 
was determined. 
 
Qualitative phytochemical screening 
The phytochemical screening of different extracts 
of the plant was performed19,20. 
 
Quatitative phytochemical analysis  
 
Total phenolic compounds 
The amounts of phenol content in the extracts were 
determined by the Folins Ciocalteu method21. The 
absorbance was measured at 765 nm using the Biorad 
iMark microplate reader. The results were expressed 
as mg gallic acid equivalents per g of plant extracts 
(mean+SD) using linear regression analysis. 
 
Total flavonoid content 
The flavonoid content of different plant extracts 
was determined by the aluminium trichloride 
method22 using iMark Bio Rad microplate reader. The 
quantity of flavonoids was expressed as mean+SD of 
mg in rutin equivalents per g of plant extracts. 
 
In vitro antioxidant activities  
 
Assay of reducing power 
Total reducing power was estimated by the method 
described by the previous reports23. Optical density 
was measured at 700 nm by using Perkin Elmer 
UV/Vis Double beam Spectrophotometer and was 
expressed as ascorbic acid equivalents. 
 
Percentage reducing power =  
 (Absorbance of test solution - Absorbance of blank) X 100 
         Absorbance of blank 
 
In vitro DPPH free radial scavenging assay  
The in vitro free radical scavenging ability of 
various plant extracts was determined by using α, 
α-Diphenyl-β-Picryl-Hydrazyl (DPPH) scavenging 
assay24 by using iMark BioRad microplate reader. The 
different plant extracts (20 mg/mL) and standard 
ascorbic acid, were used. Methanol and DPPH was 
taken as blank 
 
Percentage inhibition =  
    (Absorbance of blank - Absorbance of extract) X 100 
         Absorbance of Blank 
 
Total antioxidant capacity by FRAP method  
The total antioxidant activity of different extracts 
of L. aspera was evaluated by FRAP assay25. The 
absorbance of the coloured product (Ferrous 
tripyridyltriazine complex) was recorded at 593 nm 
by iMark Biorad microplate reader. The FRAP values 
were expressed as mM Fe (II) equivalents per mg. 
 
Total anti-oxidant capacity by ammonium molybdate assay 
The total antioxidant capacity was determined by 
the transformation of Mo (VI) to Mo (V) to form 
phosphomolybdenum complex using the method of 
Prieto et al. 26 and was expressed in g equivalent of 
ascorbic acid. 
 
Anti-elastase activity  
The effect of hexane, ethyl acetate, acetone, and 
ethanol extracts of L. aspera on porcine pancreatic 
elastase (PPE, Sigma, Type IV) was assayed by the 
method described by Siedle et al.27,28 using N-succinyl-
Ala-Ala-Ala-nitroanilide (SANA, Sigma) as the 




substrate. The release of p-nitro aniline due to 
proteolysis of N-succinyl-(Ala)-Ala-Ala-Ala-p-
Nitroanilide by porcine pancreas elastase in the 
presence and the absence of inhibitor, was monitored 
by measuring the absorbance at 410 nm using 96 well 
microplate assay. The release of p-nitroanilide from the 
substrate was monitored by measuring the optical 
density at 410 nm using a microplate reader iMark 
BioRad. The percentage inhibition of different 
concentrations of extracts of L. aspera on porcine 
pancreas elastase was calculated in comparison with 
the control without inhibitor, considering the influence 
of the buffer, substrate, solvent and test extract. Blanks 
contained all the components except the enzyme was 
also taken. Percentage inhibition of elastase was 
determined using the following equation.  
Percentage inhibition = 
control – control blank – sample –sample blank  
control – control blank
 100 
 
where the control contained enzyme and substrate 
without extract, the control blank contained only 
substrate without enzyme and extract, the sample 
contained enzyme and substrate with extract and the 
sample blank contained substrate and extract without 
enzyme. The assay was performed using triplicate 
parallel samples. IC50 values were obtained from dose-
effect curves by linear regression analysis. 
 
Statistical analysis 
Results were expressed as Mean+SD and compared 
using univariate analysis of variance followed by 
Duncan test with a significant level (α) 0.05. The  
P <0.05 was considered statistically significant. Linear 
Regression analysis was performed to derive the 
regression equation, and IC50 values were calculated. All 





Preparation of plant extracts 
The different extracts of L. aspera were prepared 
using hexane, ethyl acetate, acetone, and ethanol by 
using sequential soxhlet extraction method and 
evaporated to dryness by rotary evaporator. The yields 
of different extracts of L. aspera were found to be 46.1, 
69.1, 9.2, and 4.9 mg/g dry weight respectively. 
 
Qualitative phytochemical analysis 
Phytochemical analysis of different extracts of  
L. aspera revealed the presence of alkaloids, flavonoids, 
phenolic compounds and tannins, carbohydrates, 
proteins, oils, steroids and terpenoids in the different 
extract. Preliminary phytochemical analysis of different 
extracts of L. aspera is shown in Table 1. 
 
Quantitative phytochemical analysis 
 
 
Total phenolic compounds 
The phenol content of the plant extracts was 
determined and the results are given in Table 2 as 
mean+standard deviation of triplicates and expressed 
as mg/g plant extracts in gallic acid equivalence. In 
the present study, the total phenol compounds were 
found to be 5.851.3, 52.264.19, 36.573.23, and 
2.920.05 mg/g extract in gallic acid equivalent for 
hexane, ethyl acetate, acetone and ethanol extract 
respectively. It was found that the phenol content was 
high for ethyl acetate extract among the different 
extracts of the plant (Table 2). 
Table 1 — Qualitative phytochemical analysis 








Carbohydrate     
Molisch’s test - - + + 
Barfoed’s test - - + + 
Benedict’s test - - + + 
Fehling’s test - - + + 
Alkaloid test     
Wagner’s test - - + + 
Mayer’s test - - + + 
Flavanoids      
Alkaline reagent test - + - + 
Protein - - - + 
Biuret test     
Phenols     
Lead acetate test + + + + 
Ferric chloride test  + + + 
Oils      
Spot test + + - - 
Steroids/terpenoids     
Salkowski’s test + - - + 
 
Table 2 — Quantitative analysis of phytochemicals in Leucas 
aspera (Willd.) Link extracts 
Leucas aspera extract Total phenol  





Hexane extract 5.85 ± 1.3 - 
Ethyl acetate extract 52.26 ± 4.19 6.19 ± 1.68 
Acetone extract 36.57 ± 3.23 2.60 ± 1.21 
Ethanol extract 2.92 ± 0.05 - 
*Values expressed as  meanSD 




Estimation of flavonoid content 
The amount of flavonoid content in the ethyl 
acetate and acetone extract of L. aspera was found to 
be 6.191.68 and 2.60.21 mg/g plant extract in rutin 
equivalent respectively (Table 2). It can be concluded 
that the ethyl acetate extracts of L. aspera contain 
much more flavonoid content than acetone extract. 
 
In vitro antioxidant activity  
 
Determination of reducing power  
The present study showed the reductive capabilities 
of the different extracts of L. aspera compared to that 
of vitamin C. The percentage reducing the power of 
extracts was measured and expressed as MeanSD as 
33.133.23, 18.974.5, 52.745.33, and 291.73% 
for hexane, ethyl acetate, acetone, and ethanol 
extracts respectively and were compared statistically. 
From the results, it can be concluded that all the tested 
extracts possess the reductive capability and the 
percentage reducing capability of the acetone extract 
was significantly higher when compared with other 
extracts. Hence, the antioxidant property is more for 
acetone extract. The results are shown in Table 3. 
 
In vitro DPPH radical scavenging assay 
The percentage of DPPH radical scavenging activity 
of hexane, ethyl acetate, acetone extract and ethanol 
extract was found to be 74.644.91, 44.571.11, 
77.542.33, and 15.440.41% respectively. The results 
are shown in Table 3. In the present study percentage of 
radical scavenging activity was found to be increased in 
dose-dependent manner. Also, the acetone extract had a 
high percentage of DPPH Radical scavenging activity 
when compared to the other extracts. 
 
FRAP (Ferric reducing antioxidant power) assay 
Benzie and Strain modified method25 was adopted for 
the FRAP assay. This assay measures the ability of the 
compound to reduce the intense blue ferric 
tripyridyltriazine complex to its ferrous form, thereby 
changing its absorbance. Results are expressed in mM 
(Fe (II)/mg dry mass and compared with that of ascorbic 
acid. The results were 29.470.80, 1.69.184, 
33.876.25, and 22.861 mM (Fe (II)/mg dry mass 
respectively for hexane, ethyl acetate, acetone and 
ethanol extract of L. aspera respectively and that of 
ascorbic acid was 78.670.67 (Table 3). The acetone 
extract possessed the highest FRAP when compared 
with other extracts was found to be lower when 
compared with standard ascorbic acid (Table 3). 
 
Ammonium molybdate assay 
The antioxidant activity of the extracts was evaluated 
by analyzing the transformation of Mo (VI) to Mo (V) to 
form phosphomolybdenum complex26. The total 
antioxidant capacity of hexane, ethyl acetate, acetone, 
and ethanol extract of L. aspera were found to be 
23.87.87, 31.745.36, 44.241.0, and 18.443.7 in 
ascorbic acid equivalent respectively (Table 3). 
 
Anti-elastase assay of L. aspera  
The different concentrations of the extracts were 
prepared (10, 100, and 1000 µg/mL) in DMSO and were 
tested for their anti-elastase activity. The effects of the 
extracts on porcine pancreas elastase were evaluated and 
percentage inhibition was expressed as mean+SD. The 
results are shown in Table 4 and Fig. 1. The results 
revealed that all the extracts possessed inhibitory activity 
towards porcine pancreatic elastase and percentage 
inhibition was increased in a dose-dependent manner. 
The concentration of extract exerting 50 percentage 
inhibition (IC50) towards porcine pancreas elastase was 
calculated for each extract using linear regression 
analysis. The IC50 were found to be 247.42, 744.28, 483, 
and 409.69 (µg/mL) for hexane, ethyl acetate, acetone 
and ethanol extract respectively. It was observed that the 
hexane extract possessed significantly the highest anti-
elastase activity as it had a lower IC50 value when 
compared with other extracts at a significant level  
(α) < 0.05. 
Table 3 — Antioxidant activity of different extracts of Leucas aspera (Willd.) Link 
Sample Extract Total antioxidant activity 
(Vitamin C equivalents)* 
DPPH Scavenging 
activity (%)* 
FRAP [mM Fe 
Equivalents/mg]* 
Percentage  
reducing power (%)* 
Leucas aspera Hexane 23.8±7.87 74.64±4.91 29.47±0.808 33.13±3.23 
Ethyl acetate 31.74±5.36 44.57±1.11 1.6±9.184 18.97±4.5 
Acetone 44.24±1.0a,b,d,e 77.54±2.33b,d 33.87±6.25a,b,d 52.74±5.33a,b,d 
Ethanol 18.44±3.7 15.44±0.41 22.86±1 29±1.73 
 Ascorbic acid 85.54±0.98 94.97+.05 78.67+0.67 87.28+0 .58 
P <0.05:- a: significantly differ from hexane extract; b: significantly differ from ethyl acetate extract; c: significantly differ from acetone 
extract; d: significantly differ from ethanol extract; e:significantly differ from standard ascorbic acid 
*Values expressed as  meanSD 





The plant L. aspera is a tropical plant mainly used 
for many diseases in traditional systems of medicine9. 
The preliminary phytochemical screening revealed the 
presence of carbohydrates, proteins, phenolic 
compounds, alkaloids, flavonoids, terpenoids, 
steroids, and oils in different extracts of L. aspera. 
The quantitative analysis showed that the amount of 
total phenol content was observed to be more for ethyl 
acetate extract of L. aspera followed by acetone 
extract. The concentration of total phenolic 
compounds was found to be significantly low for 
hexane and alcohol extracts compared to the ethyl 
acetate and acetone extract. In plants of the genus 
Leucas, phenolics are found in abundance8. From the 
amount of flavonoid content in mg/g plant extract in 
rutin equivalents, it can be concluded that the ethyl 
acetate extracts of L. aspera contain much more 
flavonoid content than acetone extracts. This result 
supports the detailed review of L. aspera by Makhija 
et al.8. 
Free radicals are generated in our body due to 
oxidative stress and depletion of the dietary 
antioxidants, which may lead to an increase in  
pro-oxidant conditions for initiating diseases29. The 
present study showed that different extracts of  
L. aspera possessed significant antioxidant potential 
and reductive capability. The acetone extract 
possessed the highest antioxidant activity followed by 
ethyl acetate and alcohol extracts when compared 
statistically at a significance level of 0.05. The present 
results support the previous reports of antioxidant 
potential of L. aspera30-33. The identification of free 
radicals as the promoters of the ageing implies that 
the interventions inhibiting them should be able to 
reduce the ageing rate and disease pathogenesis34. 
Thus it can be concluded that the plant L. aspera with 
high antioxidant properties can be used for free 
radical-induced tissue damage. 
Skin-care substances of natural origin have the 
potential to inhibit matrix metalloproteases like 
elastase35. As an anti-ageing agent, elastase inhibitors 
are important in preventing skin sagging36. It was 
observed that the hexane extract possesses 
significantly higher anti-elastase activity due to its 
lower IC50 value compared with other extracts 
Table 4 — Anti-elastase activity and IC50 of different extracts of Leucas aspera (Willd.) Link 
Extract Concentration of extract 
(µg/mL)* 
Elastase inhibition (%)* Regression equation IC50 ( µg/mL) 
Hexane extract 10 33.602.03 Y=0.031X+42.330 247.42b,c,d 
100 57.751.00 
1000 72.842.77 
Ethyl acetate extract 10 15.57 0.55 Y=0.047X+ 15.01 744.28a,c,d 
100 20.761.76 
1000 61.983.43 
Acetone extract 10 22.951.52 Y=0.045X+28.26 483a,b,d 
100 42.201.52 
1000 72.282.12 
Ethanol extract 10 9.111.00 Y=0.0330X+ 36.48 409.69a,b,c 
100 33.661.37 
1000 68.354.68 
P <0.05: a = significantly differ from hexane extract; b = significantly differ from ethyl acetate extract; c = significantly differ from 
acetone extract; and d = significantly differ from ethanol extract 




Fig. 1 — Anti-elastase activity of different extracts of Leucas
aspera (Willd.) Link. 
 




(significance level (α) <0.05). It can be coordinated 
with its high DPPH Scavenging effect. The anti-
elastase effect may be due to the effect of 
phytochemical compounds present in the extract 
having free radical scavenging effect. 
Uncontrolled elastase activity may function as a 
nonspecific indicator of inflammation, infection, 
cardiovascular complications, and obesity. The elastase 
inhibitors of plant origin can be used to treat these 
complications without any side effects37. They are also 
useful as anti-ageing, anti-wrinkling, and wound healing 
agent. The present study supports the medicinal value of 
L. aspera considering its antioxidant potential and anti-
elastase activity. L. aspera was reported to contain 
various secondary metabolites7,9,38-41. The present study 




Natural products are extremely popular agents among 
the human population. From this study, it can be 
concluded that L. aspera extracts exhibited remarkable 
antioxidant and elastase inhibitory activity. Thus, the use 
of the plant for skin diseases is promising. The result 
supports the traditional use of L. aspera in skincare 
practices. A systematic screening, bioactivity guided 
purification, and characterization are essential to finding 
out the specific active constituent responsible for the 
profound therapeutic activity. The compound identified 
would be of great medicinal importance as it can be used 
to develop an effective therapeutic agent. Traditional 
knowledge coupled with scientific validation can 
provide effective remedies to eradicate diseases and to 
give betterment of mankind. 
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